- Home
- DBX vs CORT Comparison
DBX vs CORT Comparison
Compare DBX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBX
- CORT
- Stock Information
- Founded
- DBX 2007
- CORT 1998
- Country
- DBX United States
- CORT United States
- Employees
- DBX N/A
- CORT N/A
- Industry
- DBX Computer Software: Prepackaged Software
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- DBX Technology
- CORT Health Care
- Exchange
- DBX Nasdaq
- CORT Nasdaq
- Market Cap
- DBX 8.2B
- CORT 7.1B
- IPO Year
- DBX 2018
- CORT N/A
- Fundamental
- Price
- DBX $29.46
- CORT $73.36
- Analyst Decision
- DBX Buy
- CORT Strong Buy
- Analyst Count
- DBX 4
- CORT 4
- Target Price
- DBX $31.00
- CORT $142.00
- AVG Volume (30 Days)
- DBX 3.5M
- CORT 1.4M
- Earning Date
- DBX 05-08-2025
- CORT 05-05-2025
- Dividend Yield
- DBX N/A
- CORT N/A
- EPS Growth
- DBX 1.18
- CORT 8.36
- EPS
- DBX 1.48
- CORT 1.14
- Revenue
- DBX $2,541,600,000.00
- CORT $685,446,000.00
- Revenue This Year
- DBX N/A
- CORT $35.85
- Revenue Next Year
- DBX N/A
- CORT $35.22
- P/E Ratio
- DBX $19.78
- CORT $64.25
- Revenue Growth
- DBX 0.79
- CORT 30.93
- 52 Week Low
- DBX $20.68
- CORT $25.35
- 52 Week High
- DBX $33.33
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- DBX 61.53
- CORT 55.18
- Support Level
- DBX $29.04
- CORT $68.86
- Resistance Level
- DBX $30.40
- CORT $73.36
- Average True Range (ATR)
- DBX 0.68
- CORT 3.31
- MACD
- DBX 0.05
- CORT -0.08
- Stochastic Oscillator
- DBX 60.25
- CORT 75.62
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.